Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study

By LabMedica International staff writers
Posted on 29 Sep 2022

Few studies have looked at factors affecting adoption of point-of-care technologies (POCTs) among health care professionals. COVID-19 provided an opportunity to highlight the weaknesses in health care delivery systems, including a dependence on laboratory-based diagnostic technologies, and to rapidly develop novel technologies to address patient needs. Now, the findings of a new study suggest that interest among health care professionals in POCTs increased during the pandemic, with perceived applications of easy-to-use at-home, mobile or bedside devices in a broader range of diseases. Health care professionals also viewed the adoption of POCTs as facilitating the humanization of epidemiology - in other words, sharing control of disease diagnosis and management with patients, rather than continuing to be provider-driven.

So-called “gray swan events,” which are expected but unpredictable, can shift attitudes and behaviors, such as about how societies administer and provide access to health care as well as offer unique opportunities to stimulate innovation, the authors wrote. COVID-19 presented one such gray swan opportunity, according to researchers at UMass Chan Medical School (Worcester, MA, USA) and UMass Lowell (Lowell, MA, USA). In their current study, the researchers administered identical surveys to a network of health care professionals, researchers and medical device developers. The first survey was distributed from October 2019 to late March 2020. The second was distributed from late October through November 2020. Respondents were asked to name up to five conditions for which a POCT could help make a diagnosis of a disease; name up to five conditions for which a POCT could help them monitor or manage a disease; and which characteristics of POCT are most important when incorporating it into their regular practice.

Prior to the COVID-19 pandemic, health care professionals identified 18 medical condition categories for which POCTs could be used to diagnose a disease. Endocrine disorders, including diabetes mellitus, featured prominently among these, followed by infectious disease, cardiovascular and hematology conditions. Following COVID-19’s designation as a pandemic, health care professionals identified 20 medical conditions for which POCTs could be used to diagnose a disease. Infectious disease and cardiovascular-related medical conditions rose to the center of this network, followed by endocrine, respiratory and hematology conditions. Perceptions of POCTs to manage or monitor a disease also shifted. Before the pandemic, health care professionals identified cardiovascular disease as the category for which POCT was most helpful for monitoring or managing. Once COVID-19 was designated a pandemic, endocrine diseases were identified as the condition for which POCT was most useful. However, metabolic diseases experienced the greatest increase in interest.

“I believe there are many different reasons as to why point-of-care technology became more important after COVID; because the more you get used to using a technology, the more you see the benefits of having that technology,” said senior author Denise R. Dunlap, PhD, associate professor of global strategy, entrepreneurship and innovation at UMass Lowell’s Manning School of Business.

“COVID has made it so not only were point-of-care tests needed for COVID testing, but point-of-care technologies have been needed because health care is becoming more decentralized,” added UMass Chan researchers David D. McManus, MD, the Richard M. Haidack Professor in Medicine and chair and professor of medicine. “There’s no question from our paper that you could see changes in terms of acceptance of these technologies and integration into mainstream health care. People thought they were extras, but now that’s an essential ingredient in health care.”

Related Links:
UMass Chan Medical School 
UMass Lowell 

New
Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.